‘China’s Ozempic’ may vie with Eli Lilly, Novo Nordisk for global weight-loss drug market

INSUBCONTINENT EXCLUSIVE:

Drug manufacturers to focus on China and Japan, where penetration is low and innovation continues to emerge, Morgan Stanley says.